Taking a certain dose of CoQ10 for six weeks might change how genes work in people with serious kidney disease, possibly helping with inflammation and metabolism.

72

Pro

0

Against

Evidence from Studies

Supporting (1)

72

Community contributions welcome

72

A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in CKD

Randomized Controlled Trial

Human

2025 Mar 1

The study gave people with kidney disease 1200 mg of CoQ10 daily for 6 weeks and found it changed genes linked to fat processing, immunity, and stress, while also reducing inflammation—just as the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in CKD

Score: 72

DOI: 10.2215/CJN.0000000624

Similar Assertions

Taking a certain dose of CoQ10 every day for six weeks might help lower inflammation in people with moderate to severe kidney disease.

72

0

88%

Taking 1200 mg of coenzyme Q10 every day for six weeks might help lower inflammation in adults with moderate to severe kidney disease.

72

0

87%

Taking 1200 mg of CoQ10 every day for six weeks might help lower two key markers of inflammation in people with moderate to severe kidney disease, even though one of the markers didn’t stay significant when checked more strictly.

72

0

86%

Taking 1200 mg of CoQ10 every day for six weeks might help reduce harmful stress in the body for adults with moderate to severe kidney disease.

72

0

86%

Taking certain supplements like nicotinamide riboside or coenzyme Q10 might help lower signs of body stress in people with serious kidney disease.

72

0

83%